Literature DB >> 1541713

Bipolar affective disorder and substance abuse.

K T Brady1, R B Lydiard.   

Abstract

Epidemiologic data as well as data from treatment-seeking populations indicate that substance abuse disorders and other psychiatric disorders co-occur more commonly than would be expected by chance. In particular, substance abuse, especially cocaine abuse or dependence and alcoholism, is a far more common phenomenon in the population of patients with bipolar affective disorder than in the general population. National Institute of Mental Health Epidemiologic Catchment Area data indicate that bipolar affective disorder is the axis I disorder most likely to be associated with some form of substance abuse or dependence. Evidence from patient samples seeking treatment for substance abuse disorders as well as for psychiatric disorders suggests that clinical samples reflect similar patterns. There is evidence that bipolar patients with substance abuse have a worse course of illness. Diagnosing bipolar affective disorder in the face of substance abuse is difficult because the effects of drugs of abuse, particularly with chronic use, can mimic nearly any psychiatric disorder. At present, the data concerning a genetic link between bipolar affective disorder and substance abuse disorders are inconclusive. There are very few controlled data addressing either clinical features of, or specific treatment efforts with, this population. There is some theoretic rationale for the use of anticonvulsant, antikindling agents in this population, but no controlled studies have as yet been reported. In particular, a comparison of a mood-stabilizing agent, such as lithium, with an antikindling agent, such as valproate or carbamazepine, would be of theoretic and practical interest.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541713     DOI: 10.1097/00004714-199202001-00004

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  9 in total

1.  Inpatient stays for patients diagnosed with severe psychiatric disorders and substance abuse.

Authors:  C J Bradley; G A Zarkin
Journal:  Health Serv Res       Date:  1996-10       Impact factor: 3.402

2.  Is the association of alcohol use disorders with major depressive disorder a consequence of undiagnosed bipolar-II disorder?

Authors:  Jules Angst; Alex Gamma; Jérôme Endrass; Wulf Rössler; Valdeta Ajdacic-Gross; Dominique Eich; Richard Herrell; Kathleen Ries Merikangas
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08-17       Impact factor: 5.270

3.  Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression.

Authors:  David A Luckenbaugh; Lobna Ibrahim; Nancy Brutsche; Jose Franco-Chaves; Daniel Mathews; Craig A Marquardt; Christy Cassarly; Carlos A Zarate
Journal:  Bipolar Disord       Date:  2012-09-14       Impact factor: 6.744

Review 4.  The epidemiology of mood disorders.

Authors:  Kathleen Ries Merikangas; Nancy C P Low
Journal:  Curr Psychiatry Rep       Date:  2004-12       Impact factor: 5.285

5.  Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study.

Authors:  Zuowei Wang; Keming Gao; David E Kemp; Philip K Chan; Mary Beth Serrano; Carla Conroy; Yiru Fang; Stephen J Ganocy; Robert L Findling; Joseph R Calabrese
Journal:  Psychopharmacol Bull       Date:  2010

6.  Acceptability, validity and reliability of the Structured Clinical Interview for the Spectrum of Substance Use (SCI-SUBS): a pilot study.

Authors:  A Sbrana; L Dell'Osso; C Gonnelli; P Impagnatiello; M R Doria; S Spagnolli; L Ravani; G B Cassano; E Frank; M K Shear; V J Grochocinski; P Rucci; J D Maser; J Endicott
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

7.  Positive screening rates for bipolar disorder in pregnant and postpartum women and associated risk factors.

Authors:  Grace A Masters; Linda Brenckle; Padma Sankaran; Sharina D Person; Jeroan Allison; Tiffany A Moore Simas; Jean Y Ko; Cheryl L Robbins; Wendy Marsh; Nancy Byatt
Journal:  Gen Hosp Psychiatry       Date:  2019-10-22       Impact factor: 3.238

8.  A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.

Authors:  David E Kemp; Keming Gao; Stephen J Ganocy; Omar Elhaj; Sarah R Bilali; Carla Conroy; Robert L Findling; Joseph R Calabrese
Journal:  J Clin Psychiatry       Date:  2008-12-30       Impact factor: 4.384

9.  A genetic network model of cellular responses to lithium treatment and cocaine abuse in bipolar disorder.

Authors:  Richard C McEachin; Haiming Chen; Maureen A Sartor; Scott F Saccone; Benjamin J Keller; Alan R Prossin; James D Cavalcoli; Melvin G McInnis
Journal:  BMC Syst Biol       Date:  2010-11-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.